CN1813944A - External-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals - Google Patents

External-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals Download PDF

Info

Publication number
CN1813944A
CN1813944A CN 200510119627 CN200510119627A CN1813944A CN 1813944 A CN1813944 A CN 1813944A CN 200510119627 CN200510119627 CN 200510119627 CN 200510119627 A CN200510119627 A CN 200510119627A CN 1813944 A CN1813944 A CN 1813944A
Authority
CN
China
Prior art keywords
radix
traumatic injury
external
parts
activating collaterals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200510119627
Other languages
Chinese (zh)
Inventor
蓝子花
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200510119627 priority Critical patent/CN1813944A/en
Publication of CN1813944A publication Critical patent/CN1813944A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses a Chanyiteng Diedahuoluo medicine for external application for effectively curing the diseases of rheumatic arthralgia, rheumatic arthritis, arthralgia and myalgia, soft tissue injury and traumatic injury, etc. with obvious therapeutic effect. It is made up by using 5 Chinese medicinal materials of securidaca inappendiculata, bombax malabaricum root (bark), elatostema involucratum, guihuadieda and panax japonicum and adding white liquor through a certain preparation process. Its total effective rate is above 90%.

Description

A kind of external-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals
Technical field:
The present invention relates to a kind of external-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals.
Background technology:
Traumatic injury, the Fengshi Guanjie disease is a kind of common disease, the people who from ancient times to the present suffers from this disease is a lot, is subjected to ailing the torment deeply, in the market the various traumatic injury of Xiao Shouing, Fengshi Guanjie disease medicine for external use is also a lot, but no matter be Western medicine or Chinese medicine, for this class Drug therapy traumatic injury, the slight illness of Fengshi Guanjie disease has played certain therapeutical effect really, but also there is not a kind of ideal treatment traumatic injury, the specific drug of Fengshi Guanjie disease.
Summary of the invention:
The inventor has a kind of treatment traumatic injury at above-mentioned weak point at pressing for of patient, the dispelling wind and removing obstruction in the collateral analgesic medicine for external use of Fengshi Guanjie disease; The inventor, verifies and by clinical trial repeatedly through research repeatedly, finally developed a kind of with low cost, prescription rationally, preparation is simple, very easy to use, it can be to traumatic injury, and the Fengshi Guanjie disease is carried out treating both the principal and secondary aspects of a disease, reaches good therapeutic effect.
Purpose of the present invention just provides a kind of external-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals.
Choice of drug Radix securidacae of the present invention, Radix Gossampini (skin), Herba Elatostematis Involucrati, Radix et Rhizoma Dispori Cantoniensis, Chinese liquor (35-50 degree) are formed; Select Radix securidacae for use: have eliminating stasis to stop pain, relaxing muscles and tendons and activating QI and blood in the collateral; Control traumatic injury, soft tissue contusion.Select Radix Gossampini (skin) for use: have relaxing muscles and tendons and activating QI and blood in the collateral, blood circulation promoting and blood stasis dispelling; Control osteopatia sprain.Select the Herba Elatostematis Involucrati for use: have expelling wind and removing dampness, relaxing muscles and tendons and activating QI and blood in the collateral, blood circulation promoting and blood stasis dispelling; Treating rheumatic pain.Select Eriosolena involucrata (Wall.) van Tieghem for use: have relaxing muscles and tendons and activating QI and blood in the collateral, expelling wind and removing dampness, alleviating pain and detumescence; Treating rheumatic pain, traumatic injury, soft tissue contusion.Select Radix et Rhizoma Dispori Cantoniensis for use: have relaxing muscles and tendons and activating QI and blood in the collateral, expelling wind and removing dampness; Dispelling the wind and dampness pathogens arthritis, traumatic injury, soft tissue contusion.Make the effect of each medicine produce collaborative effect above these drug regimens, to sprain the curative effect of disease of pain, bones and muscles pain, wound stasis of blood pain, rheumatism bones and muscles pain, rheumatic arthritis, soft tissue contusion definite thereby can realize effectively treating rheumatic arthritis, traumatic injury stasis of blood pain, traumatic injury, muscles and bones, and effect is better.
The consumption of drug component of the present invention also is to carry out a large amount of solid lines through the inventor to grope to sum up and draw, and each amounts of components is for all to have better therapeutic effect in the following weight parts scope; It is made up of the component of following weight portion:
Radix securidacae 1-40 part, Radix Gossampini (skin) 1-35 part, Herba Elatostematis Involucrati 1-35 part, Eriosolena involucrata (Wall.) van Tieghem 1-30 part and Radix et Rhizoma Dispori Cantoniensis 1-40 part, Chinese liquor (35-50 degree) 12-540 part.Optimization formula of the present invention is:
30 parts of 30 parts of Radix securidacae, 25 parts of Radix Gossampinis (skin), 25 parts of Herba Elatostematis Involucratis, 20 parts of Eriosolena involucrata (Wall.) van Tieghems and Radix et Rhizoma Dispori Cantoniensis, 390 parts of Chinese liquor (35-50 degree).
A kind of external-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals of the present invention has relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation to remove blood stasis, an effect of the analgesia of dispeling the wind; Be applicable to that treatment rheumatic arthritis, traumatic injury stasis of blood pain, traumatic injury, muscles and bones sprain the disease of pain, bones and muscles pain, wound stasis of blood pain, rheumatism bones and muscles pain, rheumatic arthritis, soft tissue contusion; Be a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compares better efficacy with existing similar medicine for external use curative effect.A kind of external-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals of the present invention was once done a large amount of clinical trials in early stage, inferior to over one hundred example on the patient treatment case before this, comprise being used for the treatment of the disease that rheumatic arthritis, traumatic injury stasis of blood pain, traumatic injury, muscles and bones are sprained pain, bones and muscles pain, wound stasis of blood pain, rheumatism bones and muscles pain, rheumatic arthritis, soft tissue contusion, do not see untoward reaction during the treatment; General patient's medication can be cured in 1-60 days, and total effective rate is more than 90%, and therapeutic effect is very good.
Using method:
This medicine is a medicine for external use, and oral administration is cleaned the affected part with hot water, dabs in the affected part with the drenched medicinal liquid of absorbent cotton, and affected part is wiped to generating heat for good every day 3-6 time.
The specific embodiment:
Describe embodiments of the invention below in detail:
Embodiment 1:
A kind of external-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals provided by the present invention is made up of the component of following weight portion; Radix securidacae 1-40 part, Radix Gossampini (skin) 1-35 part, Herba Elatostematis Involucrati 1-35 part, Eriosolena involucrata (Wall.) van Tieghem 1-30 part and Radix et Rhizoma Dispori Cantoniensis 1-40 part, Chinese liquor (35-50 degree) 12-540 part.
Embodiment 2:
Optimization formula of the present invention is:
30 parts of 30 parts of Radix securidacae, 25 parts of Radix Gossampinis (skin), 25 parts of Herba Elatostematis Involucratis, 20 parts of Eriosolena involucrata (Wall.) van Tieghems and Radix et Rhizoma Dispori Cantoniensis, 390 parts of Chinese liquor (35-50 degree).
Preparation method of the present invention is: at first with above-mentioned Radix securidacae, Radix Gossampini (skin), Herba Elatostematis Involucrati, Eriosolena involucrata (Wall.) van Tieghem, Radix et Rhizoma Dispori Cantoniensis, single chopping respectively, to be mixed in proportion together after each single chopping, be placed in the container then, and allocate Chinese liquor (35-50 degree) into, stir in the sealed container of back, according to the modern Chinese medicine processing technology or soaked 7-20 days, the mixture solution after handling packed into by the required metering of client to get product in the bottle.

Claims (3)

1, a kind of external-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals is characterized in that: Radix securidacae, Radix Gossampini (skin), Herba Elatostematis Involucrati, Eriosolena involucrata (Wall.) van Tieghem and Radix et Rhizoma Dispori Cantoniensis are formed.
2, a kind of external-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals according to claim 1, it is characterized in that: the component by following weight portion is formed; Radix securidacae 1-40 part, Radix Gossampini (skin) 1-35 part, Herba Elatostematis Involucrati 1-35 part, Eriosolena involucrata (Wall.) van Tieghem 1-30 part and Radix et Rhizoma Dispori Cantoniensis 1-40 part.
3, a kind of external-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals according to claim 1, it is characterized in that: the component by following weight portion is formed; 30 parts of 30 parts of Radix securidacae, 25 parts of Radix Gossampinis (skin), 25 parts of Herba Elatostematis Involucratis, 20 parts of Eriosolena involucrata (Wall.) van Tieghems and Radix et Rhizoma Dispori Cantoniensis.
CN 200510119627 2005-11-24 2005-11-24 External-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals Pending CN1813944A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200510119627 CN1813944A (en) 2005-11-24 2005-11-24 External-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200510119627 CN1813944A (en) 2005-11-24 2005-11-24 External-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals

Publications (1)

Publication Number Publication Date
CN1813944A true CN1813944A (en) 2006-08-09

Family

ID=36906376

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200510119627 Pending CN1813944A (en) 2005-11-24 2005-11-24 External-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals

Country Status (1)

Country Link
CN (1) CN1813944A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103272180A (en) * 2013-05-23 2013-09-04 王成红 Externally-applied Chinese medicine preparation for treating hysteromyoma
CN106389696A (en) * 2016-11-02 2017-02-15 杨均初 Traditional Chinese medicine composition for treating traumatic injury and preparation method thereof
WO2018132256A1 (en) * 2017-01-16 2018-07-19 Jin Xin Biotechnology Co., Ltd. Method for treating osteoarthritis

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103272180A (en) * 2013-05-23 2013-09-04 王成红 Externally-applied Chinese medicine preparation for treating hysteromyoma
CN103272180B (en) * 2013-05-23 2014-07-23 王成红 Externally-applied Chinese medicine preparation for treating hysteromyoma
CN106389696A (en) * 2016-11-02 2017-02-15 杨均初 Traditional Chinese medicine composition for treating traumatic injury and preparation method thereof
WO2018132256A1 (en) * 2017-01-16 2018-07-19 Jin Xin Biotechnology Co., Ltd. Method for treating osteoarthritis

Similar Documents

Publication Publication Date Title
CN1742895A (en) External-use medicine of Herba sarcandrae
CN1813944A (en) External-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals
CN100506253C (en) Collateral-flow-activating external-use medicine of Radix Seu Folium Clematidis Henryi for treating injuries by falls
CN100420476C (en) Collateral-flow-activating external-use medicine of Herba et Radix Inebriantis for treating injuries by falls
CN1742816A (en) Wujiaofeng root external-use medicine
CN1813928A (en) External-use drug of canavalia gladiata for traumatic injury and activating collaterals
CN1813898A (en) External-use medicine of hayberry bark for traumatic injury and activating collaterals
CN1813992A (en) Radix-zauthoxyli-Plamispini external-use collateral-flow-activating medicine for treating injuries from falls
CN1742801A (en) Qianjinba external-use medicine
CN1762469A (en) Externally applied medicine of madeira vine
CN1739711A (en) Externally applied medicine of rhodiola root
CN1739693A (en) Externally applied medicine of dunn tongoloa root
CN1739624A (en) Externally applied medicine of aizoon stonecrop root
CN1813864A (en) External-use medicine of thickleaf croton root for traumatic injury and activating collaterals
CN1813907A (en) External-use medicine of cordateleaf ainsliaea root for traumatic injury and activating collaterals
CN1813990A (en) Cortex Berheridis Radicis external-use medicine
CN1813854A (en) External-use medicine of herb of seguin cobelia for traumatic injury and activating collaterals
CN1814104A (en) Wind-repellent collateral-flow-activating pain-relieving medicine of Radix seu Folium Lobeliae Seguinit
CN1813963A (en) External medicine of Herbaet Rhizoma Begoniae cavalerei for treating traumatic injuries and activating collateral flows
CN1813942A (en) External-use drug of helwingia himalaicahook for traumatic injury and activating collaterals
CN1742907A (en) External-use medicine of Radix celastri orbiculati
CN1742839A (en) Nutritious health-care oral liquor for woman and preparing process
CN1751709A (en) External use medicine for treating traumatic injury
CN1739708A (en) Externally applied medicine of cannalike dona rhizome
CN1814016A (en) Collateral-flow-activating external-use medicine of Fodium Desmoris for treating injuries from falls

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication